Reply to: Ricolinostat is not a highly selective HDAC6 inhibitor

Jose Silva, Jiyang Yu, Kevin Kalinsky

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Access to Document

@article{934a7dd025a649afb88811392e8c4c63,

title = "Reply to: Ricolinostat is not a highly selective HDAC6 inhibitor",

author = "Jose Silva and Jiyang Yu and Kevin Kalinsky",

year = "2023",

month = jun,

doi = "10.1038/s43018-023-00583-2",

language = "English",

volume = "4",

pages = "809--811",

journal = "Nature Cancer",

issn = "2662-1347",

publisher = "Nature Research",

number = "6",

}

TY - JOUR

T1 - Reply to

T2 - Ricolinostat is not a highly selective HDAC6 inhibitor

AU - Silva, Jose

AU - Yu, Jiyang

AU - Kalinsky, Kevin

PY - 2023/6

Y1 - 2023/6

UR - http://www.scopus.com/inward/record.url?scp=85161839125&partnerID=8YFLogxK

U2 - 10.1038/s43018-023-00583-2

DO - 10.1038/s43018-023-00583-2

M3 - Letter

AN - SCOPUS:85161839125

SN - 2662-1347

VL - 4

SP - 809

EP - 811

JO - Nature Cancer

JF - Nature Cancer

IS - 6

ER -